nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Ifosfamide—germ cell cancer	0.183	0.251	CbGbCtD
Rivaroxaban—ABCB1—Dactinomycin—germ cell cancer	0.101	0.138	CbGbCtD
Rivaroxaban—CYP3A5—Etoposide—germ cell cancer	0.0876	0.12	CbGbCtD
Rivaroxaban—CYP3A4—Ifosfamide—germ cell cancer	0.0714	0.0977	CbGbCtD
Rivaroxaban—ABCB1—Vinblastine—germ cell cancer	0.0633	0.0865	CbGbCtD
Rivaroxaban—ABCB1—Cisplatin—germ cell cancer	0.058	0.0793	CbGbCtD
Rivaroxaban—ABCB1—Etoposide—germ cell cancer	0.057	0.0779	CbGbCtD
Rivaroxaban—CYP3A4—Vinblastine—germ cell cancer	0.0379	0.0518	CbGbCtD
Rivaroxaban—ABCB1—Methotrexate—germ cell cancer	0.0376	0.0515	CbGbCtD
Rivaroxaban—CYP3A4—Etoposide—germ cell cancer	0.0341	0.0467	CbGbCtD
Rivaroxaban—CYP2J2—blood vessel—germ cell cancer	0.0057	0.0912	CbGeAlD
Rivaroxaban—CYP2J2—trigeminal ganglion—germ cell cancer	0.00352	0.0563	CbGeAlD
Rivaroxaban—F10—decidua—germ cell cancer	0.0032	0.0512	CbGeAlD
Rivaroxaban—CYP3A4—urine—germ cell cancer	0.00278	0.0445	CbGeAlD
Rivaroxaban—CYP2J2—telencephalon—germ cell cancer	0.00276	0.0442	CbGeAlD
Rivaroxaban—CYP2J2—skin of body—germ cell cancer	0.00264	0.0422	CbGeAlD
Rivaroxaban—F10—adrenal gland—germ cell cancer	0.00245	0.0393	CbGeAlD
Rivaroxaban—CYP2J2—uterus—germ cell cancer	0.00229	0.0367	CbGeAlD
Rivaroxaban—F10—female gonad—germ cell cancer	0.00229	0.0366	CbGeAlD
Rivaroxaban—CYP2J2—pituitary gland—germ cell cancer	0.00225	0.036	CbGeAlD
Rivaroxaban—CYP2J2—medulla oblongata—germ cell cancer	0.00217	0.0348	CbGeAlD
Rivaroxaban—F10—endocrine gland—germ cell cancer	0.00213	0.0341	CbGeAlD
Rivaroxaban—F10—head—germ cell cancer	0.0021	0.0336	CbGeAlD
Rivaroxaban—F10—testis—germ cell cancer	0.00203	0.0325	CbGeAlD
Rivaroxaban—CYP2J2—midbrain—germ cell cancer	0.00199	0.0318	CbGeAlD
Rivaroxaban—CYP2J2—spinal cord—germ cell cancer	0.00194	0.031	CbGeAlD
Rivaroxaban—CYP2J2—endocrine gland—germ cell cancer	0.00174	0.0279	CbGeAlD
Rivaroxaban—CYP2J2—head—germ cell cancer	0.00172	0.0276	CbGeAlD
Rivaroxaban—CYP2J2—testis—germ cell cancer	0.00166	0.0266	CbGeAlD
Rivaroxaban—CYP2J2—cerebellum—germ cell cancer	0.00154	0.0246	CbGeAlD
Rivaroxaban—F10—lymph node—germ cell cancer	0.00147	0.0235	CbGeAlD
Rivaroxaban—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00137	0.00665	CcSEcCtD
Rivaroxaban—Renal failure acute—Cisplatin—germ cell cancer	0.00137	0.00663	CcSEcCtD
Rivaroxaban—Swelling—Etoposide—germ cell cancer	0.00131	0.00635	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Cisplatin—germ cell cancer	0.00126	0.00612	CcSEcCtD
Rivaroxaban—Haematuria—Bleomycin—germ cell cancer	0.00126	0.0061	CcSEcCtD
Rivaroxaban—CYP2J2—brain—germ cell cancer	0.00125	0.02	CbGeAlD
Rivaroxaban—Angina pectoris—Ifosfamide—germ cell cancer	0.00123	0.00598	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00122	0.00592	CcSEcCtD
Rivaroxaban—Haemoglobin—Bleomycin—germ cell cancer	0.00119	0.00577	CcSEcCtD
Rivaroxaban—Haemorrhage—Bleomycin—germ cell cancer	0.00119	0.00575	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Cisplatin—germ cell cancer	0.00118	0.00573	CcSEcCtD
Rivaroxaban—Agranulocytosis—Dactinomycin—germ cell cancer	0.00115	0.00557	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Vinblastine—germ cell cancer	0.00113	0.00549	CcSEcCtD
Rivaroxaban—Anaemia—Vinblastine—germ cell cancer	0.00113	0.00547	CcSEcCtD
Rivaroxaban—Infestation NOS—Ifosfamide—germ cell cancer	0.00113	0.00547	CcSEcCtD
Rivaroxaban—Infestation—Ifosfamide—germ cell cancer	0.00113	0.00547	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00112	0.00542	CcSEcCtD
Rivaroxaban—Renal failure—Ifosfamide—germ cell cancer	0.00111	0.00538	CcSEcCtD
Rivaroxaban—Hepatitis—Dactinomycin—germ cell cancer	0.00111	0.00536	CcSEcCtD
Rivaroxaban—Malaise—Vinblastine—germ cell cancer	0.0011	0.00534	CcSEcCtD
Rivaroxaban—Haematuria—Ifosfamide—germ cell cancer	0.00108	0.00521	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00107	0.00517	CcSEcCtD
Rivaroxaban—ABCB1—blood vessel—germ cell cancer	0.00107	0.0171	CbGeAlD
Rivaroxaban—Agranulocytosis—Ifosfamide—germ cell cancer	0.00105	0.0051	CcSEcCtD
Rivaroxaban—Erythema multiforme—Dactinomycin—germ cell cancer	0.00105	0.00507	CcSEcCtD
Rivaroxaban—Discomfort—Vinblastine—germ cell cancer	0.00103	0.00498	CcSEcCtD
Rivaroxaban—Haemoglobin—Ifosfamide—germ cell cancer	0.00102	0.00493	CcSEcCtD
Rivaroxaban—Haemorrhage—Ifosfamide—germ cell cancer	0.00101	0.00491	CcSEcCtD
Rivaroxaban—Hepatitis—Ifosfamide—germ cell cancer	0.00101	0.00491	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Ifosfamide—germ cell cancer	0.001	0.00485	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000996	0.00482	CcSEcCtD
Rivaroxaban—Urethral disorder—Ifosfamide—germ cell cancer	0.000993	0.00481	CcSEcCtD
Rivaroxaban—Erythema multiforme—Ifosfamide—germ cell cancer	0.000958	0.00464	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Bleomycin—germ cell cancer	0.000958	0.00464	CcSEcCtD
Rivaroxaban—Renal failure—Cisplatin—germ cell cancer	0.000957	0.00464	CcSEcCtD
Rivaroxaban—Anaemia—Bleomycin—germ cell cancer	0.000954	0.00462	CcSEcCtD
Rivaroxaban—Eye disorder—Ifosfamide—germ cell cancer	0.000947	0.00459	CcSEcCtD
Rivaroxaban—Cardiac disorder—Ifosfamide—germ cell cancer	0.000941	0.00456	CcSEcCtD
Rivaroxaban—Malaise—Bleomycin—germ cell cancer	0.000931	0.00451	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000921	0.00446	CcSEcCtD
Rivaroxaban—Angiopathy—Ifosfamide—germ cell cancer	0.00092	0.00445	CcSEcCtD
Rivaroxaban—Immune system disorder—Ifosfamide—germ cell cancer	0.000915	0.00443	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000913	0.00443	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000893	0.00433	CcSEcCtD
Rivaroxaban—Infestation—Etoposide—germ cell cancer	0.000892	0.00432	CcSEcCtD
Rivaroxaban—Infestation NOS—Etoposide—germ cell cancer	0.000892	0.00432	CcSEcCtD
Rivaroxaban—Anaemia—Dactinomycin—germ cell cancer	0.00089	0.00431	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000884	0.00428	CcSEcCtD
Rivaroxaban—Chest pain—Bleomycin—germ cell cancer	0.000879	0.00426	CcSEcCtD
Rivaroxaban—Renal failure—Etoposide—germ cell cancer	0.000877	0.00425	CcSEcCtD
Rivaroxaban—Jaundice—Etoposide—germ cell cancer	0.000869	0.00421	CcSEcCtD
Rivaroxaban—Discomfort—Bleomycin—germ cell cancer	0.000868	0.00421	CcSEcCtD
Rivaroxaban—Malaise—Dactinomycin—germ cell cancer	0.000868	0.00421	CcSEcCtD
Rivaroxaban—Ecchymosis—Methotrexate—germ cell cancer	0.000863	0.00418	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Cisplatin—germ cell cancer	0.000863	0.00418	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Cisplatin—germ cell cancer	0.000859	0.00416	CcSEcCtD
Rivaroxaban—Urethral disorder—Cisplatin—germ cell cancer	0.000856	0.00415	CcSEcCtD
Rivaroxaban—Constipation—Vinblastine—germ cell cancer	0.000853	0.00413	CcSEcCtD
Rivaroxaban—Pain—Vinblastine—germ cell cancer	0.000853	0.00413	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Etoposide—germ cell cancer	0.000843	0.00409	CcSEcCtD
Rivaroxaban—Oedema—Bleomycin—germ cell cancer	0.000843	0.00408	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Bleomycin—germ cell cancer	0.000843	0.00408	CcSEcCtD
Rivaroxaban—Infection—Bleomycin—germ cell cancer	0.000837	0.00405	CcSEcCtD
Rivaroxaban—Agranulocytosis—Etoposide—germ cell cancer	0.000832	0.00403	CcSEcCtD
Rivaroxaban—Feeling abnormal—Vinblastine—germ cell cancer	0.000822	0.00398	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000819	0.00397	CcSEcCtD
Rivaroxaban—Eye disorder—Cisplatin—germ cell cancer	0.000817	0.00396	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000816	0.00395	CcSEcCtD
Rivaroxaban—Anaemia—Ifosfamide—germ cell cancer	0.000815	0.00395	CcSEcCtD
Rivaroxaban—Cardiac disorder—Cisplatin—germ cell cancer	0.000811	0.00393	CcSEcCtD
Rivaroxaban—Discomfort—Dactinomycin—germ cell cancer	0.00081	0.00392	CcSEcCtD
Rivaroxaban—Angioedema—Ifosfamide—germ cell cancer	0.000806	0.00391	CcSEcCtD
Rivaroxaban—Malaise—Ifosfamide—germ cell cancer	0.000796	0.00385	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Etoposide—germ cell cancer	0.000791	0.00383	CcSEcCtD
Rivaroxaban—Immune system disorder—Cisplatin—germ cell cancer	0.000789	0.00382	CcSEcCtD
Rivaroxaban—Abdominal pain—Vinblastine—germ cell cancer	0.000789	0.00382	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Cisplatin—germ cell cancer	0.000787	0.00381	CcSEcCtD
Rivaroxaban—Hypotension—Bleomycin—germ cell cancer	0.000787	0.00381	CcSEcCtD
Rivaroxaban—Oedema—Dactinomycin—germ cell cancer	0.000786	0.00381	CcSEcCtD
Rivaroxaban—Urethral disorder—Etoposide—germ cell cancer	0.000785	0.0038	CcSEcCtD
Rivaroxaban—Infection—Dactinomycin—germ cell cancer	0.000781	0.00378	CcSEcCtD
Rivaroxaban—Erythema multiforme—Etoposide—germ cell cancer	0.000757	0.00367	CcSEcCtD
Rivaroxaban—Dyspnoea—Bleomycin—germ cell cancer	0.000751	0.00364	CcSEcCtD
Rivaroxaban—Chest pain—Ifosfamide—germ cell cancer	0.000751	0.00364	CcSEcCtD
Rivaroxaban—Renal failure acute—Methotrexate—germ cell cancer	0.000751	0.00364	CcSEcCtD
Rivaroxaban—Eye disorder—Etoposide—germ cell cancer	0.000748	0.00362	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000746	0.00361	CcSEcCtD
Rivaroxaban—Cardiac disorder—Etoposide—germ cell cancer	0.000743	0.0036	CcSEcCtD
Rivaroxaban—Discomfort—Ifosfamide—germ cell cancer	0.000742	0.0036	CcSEcCtD
Rivaroxaban—Hypersensitivity—Vinblastine—germ cell cancer	0.000735	0.00356	CcSEcCtD
Rivaroxaban—Muscle spasms—Cisplatin—germ cell cancer	0.000731	0.00354	CcSEcCtD
Rivaroxaban—Angiopathy—Etoposide—germ cell cancer	0.000726	0.00352	CcSEcCtD
Rivaroxaban—Immune system disorder—Etoposide—germ cell cancer	0.000723	0.0035	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Etoposide—germ cell cancer	0.000721	0.00349	CcSEcCtD
Rivaroxaban—Pain—Bleomycin—germ cell cancer	0.00072	0.00349	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00072	0.00349	CcSEcCtD
Rivaroxaban—Oedema—Ifosfamide—germ cell cancer	0.00072	0.00349	CcSEcCtD
Rivaroxaban—Asthenia—Vinblastine—germ cell cancer	0.000716	0.00347	CcSEcCtD
Rivaroxaban—Infection—Ifosfamide—germ cell cancer	0.000715	0.00347	CcSEcCtD
Rivaroxaban—Nervous system disorder—Ifosfamide—germ cell cancer	0.000706	0.00342	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Cisplatin—germ cell cancer	0.000706	0.00342	CcSEcCtD
Rivaroxaban—Anaemia—Cisplatin—germ cell cancer	0.000703	0.00341	CcSEcCtD
Rivaroxaban—Skin disorder—Ifosfamide—germ cell cancer	0.000699	0.00339	CcSEcCtD
Rivaroxaban—Feeling abnormal—Bleomycin—germ cell cancer	0.000694	0.00336	CcSEcCtD
Rivaroxaban—Osteoarthritis—Methotrexate—germ cell cancer	0.000693	0.00336	CcSEcCtD
Rivaroxaban—Malaise—Cisplatin—germ cell cancer	0.000686	0.00332	CcSEcCtD
Rivaroxaban—Diarrhoea—Vinblastine—germ cell cancer	0.000683	0.00331	CcSEcCtD
Rivaroxaban—Fatigue—Dactinomycin—germ cell cancer	0.000677	0.00328	CcSEcCtD
Rivaroxaban—Back pain—Etoposide—germ cell cancer	0.000674	0.00327	CcSEcCtD
Rivaroxaban—Hypotension—Ifosfamide—germ cell cancer	0.000673	0.00326	CcSEcCtD
Rivaroxaban—Pain—Dactinomycin—germ cell cancer	0.000672	0.00326	CcSEcCtD
Rivaroxaban—Muscle spasms—Etoposide—germ cell cancer	0.00067	0.00325	CcSEcCtD
Rivaroxaban—Urticaria—Bleomycin—germ cell cancer	0.000669	0.00324	CcSEcCtD
Rivaroxaban—CYP3A5—female gonad—germ cell cancer	0.00066	0.0106	CbGeAlD
Rivaroxaban—Dizziness—Vinblastine—germ cell cancer	0.00066	0.0032	CcSEcCtD
Rivaroxaban—ABCB1—trigeminal ganglion—germ cell cancer	0.000658	0.0105	CbGeAlD
Rivaroxaban—Feeling abnormal—Dactinomycin—germ cell cancer	0.000648	0.00314	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Etoposide—germ cell cancer	0.000647	0.00313	CcSEcCtD
Rivaroxaban—Anaemia—Etoposide—germ cell cancer	0.000644	0.00312	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000643	0.00312	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000643	0.00311	CcSEcCtD
Rivaroxaban—Dyspnoea—Ifosfamide—germ cell cancer	0.000642	0.00311	CcSEcCtD
Rivaroxaban—Discomfort—Cisplatin—germ cell cancer	0.00064	0.0031	CcSEcCtD
Rivaroxaban—ABCB1—embryo—germ cell cancer	0.000636	0.0102	CbGeAlD
Rivaroxaban—Vomiting—Vinblastine—germ cell cancer	0.000634	0.00307	CcSEcCtD
Rivaroxaban—Malaise—Etoposide—germ cell cancer	0.000628	0.00304	CcSEcCtD
Rivaroxaban—Headache—Vinblastine—germ cell cancer	0.000625	0.00303	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000622	0.00301	CcSEcCtD
Rivaroxaban—Abdominal pain—Dactinomycin—germ cell cancer	0.000621	0.00301	CcSEcCtD
Rivaroxaban—Fatigue—Ifosfamide—germ cell cancer	0.000621	0.00301	CcSEcCtD
Rivaroxaban—Oedema—Cisplatin—germ cell cancer	0.000621	0.00301	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Cisplatin—germ cell cancer	0.000621	0.00301	CcSEcCtD
Rivaroxaban—Hypersensitivity—Bleomycin—germ cell cancer	0.000621	0.00301	CcSEcCtD
Rivaroxaban—Infection—Cisplatin—germ cell cancer	0.000617	0.00299	CcSEcCtD
Rivaroxaban—Pain—Ifosfamide—germ cell cancer	0.000616	0.00298	CcSEcCtD
Rivaroxaban—Constipation—Ifosfamide—germ cell cancer	0.000616	0.00298	CcSEcCtD
Rivaroxaban—CYP3A5—endocrine gland—germ cell cancer	0.000614	0.00982	CbGeAlD
Rivaroxaban—Loss of consciousness—Etoposide—germ cell cancer	0.000612	0.00297	CcSEcCtD
Rivaroxaban—Nervous system disorder—Cisplatin—germ cell cancer	0.000609	0.00295	CcSEcCtD
Rivaroxaban—Tachycardia—Cisplatin—germ cell cancer	0.000606	0.00294	CcSEcCtD
Rivaroxaban—Asthenia—Bleomycin—germ cell cancer	0.000604	0.00293	CcSEcCtD
Rivaroxaban—Skin disorder—Cisplatin—germ cell cancer	0.000603	0.00292	CcSEcCtD
Rivaroxaban—Pruritus—Bleomycin—germ cell cancer	0.000596	0.00289	CcSEcCtD
Rivaroxaban—Feeling abnormal—Ifosfamide—germ cell cancer	0.000593	0.00287	CcSEcCtD
Rivaroxaban—Chest pain—Etoposide—germ cell cancer	0.000593	0.00287	CcSEcCtD
Rivaroxaban—Nausea—Vinblastine—germ cell cancer	0.000593	0.00287	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000589	0.00285	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000589	0.00285	CcSEcCtD
Rivaroxaban—Discomfort—Etoposide—germ cell cancer	0.000586	0.00284	CcSEcCtD
Rivaroxaban—Hypotension—Cisplatin—germ cell cancer	0.00058	0.00281	CcSEcCtD
Rivaroxaban—Hypersensitivity—Dactinomycin—germ cell cancer	0.000579	0.0028	CcSEcCtD
Rivaroxaban—Urticaria—Ifosfamide—germ cell cancer	0.000572	0.00277	CcSEcCtD
Rivaroxaban—Abdominal pain—Ifosfamide—germ cell cancer	0.000569	0.00276	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Etoposide—germ cell cancer	0.000569	0.00276	CcSEcCtD
Rivaroxaban—Infection—Etoposide—germ cell cancer	0.000565	0.00274	CcSEcCtD
Rivaroxaban—Asthenia—Dactinomycin—germ cell cancer	0.000564	0.00273	CcSEcCtD
Rivaroxaban—ABCB1—retina—germ cell cancer	0.000562	0.00899	CbGeAlD
Rivaroxaban—Tachycardia—Etoposide—germ cell cancer	0.000555	0.00269	CcSEcCtD
Rivaroxaban—Dyspnoea—Cisplatin—germ cell cancer	0.000553	0.00268	CcSEcCtD
Rivaroxaban—Skin disorder—Etoposide—germ cell cancer	0.000552	0.00268	CcSEcCtD
Rivaroxaban—Diarrhoea—Dactinomycin—germ cell cancer	0.000538	0.0026	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000536	0.0026	CcSEcCtD
Rivaroxaban—Vomiting—Bleomycin—germ cell cancer	0.000536	0.0026	CcSEcCtD
Rivaroxaban—Infestation NOS—Methotrexate—germ cell cancer	0.000534	0.00259	CcSEcCtD
Rivaroxaban—Infestation—Methotrexate—germ cell cancer	0.000534	0.00259	CcSEcCtD
Rivaroxaban—Hypotension—Etoposide—germ cell cancer	0.000531	0.00257	CcSEcCtD
Rivaroxaban—Rash—Bleomycin—germ cell cancer	0.000531	0.00257	CcSEcCtD
Rivaroxaban—Pain—Cisplatin—germ cell cancer	0.000531	0.00257	CcSEcCtD
Rivaroxaban—Dermatitis—Bleomycin—germ cell cancer	0.000531	0.00257	CcSEcCtD
Rivaroxaban—Hypersensitivity—Ifosfamide—germ cell cancer	0.000531	0.00257	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00053	0.00257	CcSEcCtD
Rivaroxaban—Renal failure—Methotrexate—germ cell cancer	0.000525	0.00254	CcSEcCtD
Rivaroxaban—ABCB1—telencephalon—germ cell cancer	0.000517	0.00827	CbGeAlD
Rivaroxaban—Asthenia—Ifosfamide—germ cell cancer	0.000517	0.0025	CcSEcCtD
Rivaroxaban—Feeling abnormal—Cisplatin—germ cell cancer	0.000512	0.00248	CcSEcCtD
Rivaroxaban—Pruritus—Ifosfamide—germ cell cancer	0.000509	0.00247	CcSEcCtD
Rivaroxaban—Haematuria—Methotrexate—germ cell cancer	0.000509	0.00247	CcSEcCtD
Rivaroxaban—Dyspnoea—Etoposide—germ cell cancer	0.000507	0.00246	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000505	0.00245	CcSEcCtD
Rivaroxaban—Epistaxis—Methotrexate—germ cell cancer	0.000504	0.00244	CcSEcCtD
Rivaroxaban—Nausea—Bleomycin—germ cell cancer	0.0005	0.00242	CcSEcCtD
Rivaroxaban—Vomiting—Dactinomycin—germ cell cancer	0.0005	0.00242	CcSEcCtD
Rivaroxaban—Agranulocytosis—Methotrexate—germ cell cancer	0.000498	0.00241	CcSEcCtD
Rivaroxaban—Rash—Dactinomycin—germ cell cancer	0.000495	0.0024	CcSEcCtD
Rivaroxaban—Diarrhoea—Ifosfamide—germ cell cancer	0.000493	0.00239	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000491	0.00238	CcSEcCtD
Rivaroxaban—Fatigue—Etoposide—germ cell cancer	0.00049	0.00238	CcSEcCtD
Rivaroxaban—ABCB1—decidua—germ cell cancer	0.00049	0.00784	CbGeAlD
Rivaroxaban—Pain—Etoposide—germ cell cancer	0.000486	0.00236	CcSEcCtD
Rivaroxaban—Constipation—Etoposide—germ cell cancer	0.000486	0.00236	CcSEcCtD
Rivaroxaban—Haemoglobin—Methotrexate—germ cell cancer	0.000482	0.00233	CcSEcCtD
Rivaroxaban—Haemorrhage—Methotrexate—germ cell cancer	0.000479	0.00232	CcSEcCtD
Rivaroxaban—Hepatitis—Methotrexate—germ cell cancer	0.000479	0.00232	CcSEcCtD
Rivaroxaban—Dizziness—Ifosfamide—germ cell cancer	0.000476	0.00231	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Methotrexate—germ cell cancer	0.000474	0.00229	CcSEcCtD
Rivaroxaban—Urethral disorder—Methotrexate—germ cell cancer	0.00047	0.00228	CcSEcCtD
Rivaroxaban—Feeling abnormal—Etoposide—germ cell cancer	0.000469	0.00227	CcSEcCtD
Rivaroxaban—Nausea—Dactinomycin—germ cell cancer	0.000467	0.00226	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Etoposide—germ cell cancer	0.000465	0.00225	CcSEcCtD
Rivaroxaban—CYP3A4—endocrine gland—germ cell cancer	0.000461	0.00737	CbGeAlD
Rivaroxaban—Vomiting—Ifosfamide—germ cell cancer	0.000458	0.00222	CcSEcCtD
Rivaroxaban—Hypersensitivity—Cisplatin—germ cell cancer	0.000457	0.00222	CcSEcCtD
Rivaroxaban—Rash—Ifosfamide—germ cell cancer	0.000454	0.0022	CcSEcCtD
Rivaroxaban—Dermatitis—Ifosfamide—germ cell cancer	0.000454	0.0022	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—germ cell cancer	0.000453	0.0022	CcSEcCtD
Rivaroxaban—Urticaria—Etoposide—germ cell cancer	0.000452	0.00219	CcSEcCtD
Rivaroxaban—Abdominal pain—Etoposide—germ cell cancer	0.00045	0.00218	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—germ cell cancer	0.000448	0.00217	CcSEcCtD
Rivaroxaban—Asthenia—Cisplatin—germ cell cancer	0.000445	0.00216	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methotrexate—germ cell cancer	0.000445	0.00216	CcSEcCtD
Rivaroxaban—Angiopathy—Methotrexate—germ cell cancer	0.000435	0.00211	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—germ cell cancer	0.000433	0.0021	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—germ cell cancer	0.000432	0.00209	CcSEcCtD
Rivaroxaban—ABCB1—gonad—germ cell cancer	0.000431	0.0069	CbGeAlD
Rivaroxaban—ABCB1—uterus—germ cell cancer	0.000429	0.00686	CbGeAlD
Rivaroxaban—Nausea—Ifosfamide—germ cell cancer	0.000428	0.00207	CcSEcCtD
Rivaroxaban—Diarrhoea—Cisplatin—germ cell cancer	0.000425	0.00206	CcSEcCtD
Rivaroxaban—ABCB1—pituitary gland—germ cell cancer	0.000421	0.00674	CbGeAlD
Rivaroxaban—Hypersensitivity—Etoposide—germ cell cancer	0.000419	0.00203	CcSEcCtD
Rivaroxaban—Asthenia—Etoposide—germ cell cancer	0.000408	0.00198	CcSEcCtD
Rivaroxaban—ABCB1—medulla oblongata—germ cell cancer	0.000406	0.0065	CbGeAlD
Rivaroxaban—Back pain—Methotrexate—germ cell cancer	0.000404	0.00196	CcSEcCtD
Rivaroxaban—Pruritus—Etoposide—germ cell cancer	0.000402	0.00195	CcSEcCtD
Rivaroxaban—Vomiting—Cisplatin—germ cell cancer	0.000395	0.00191	CcSEcCtD
Rivaroxaban—Rash—Cisplatin—germ cell cancer	0.000391	0.0019	CcSEcCtD
Rivaroxaban—Dermatitis—Cisplatin—germ cell cancer	0.000391	0.00189	CcSEcCtD
Rivaroxaban—Diarrhoea—Etoposide—germ cell cancer	0.000389	0.00189	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—germ cell cancer	0.000387	0.00188	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—germ cell cancer	0.000386	0.00187	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—germ cell cancer	0.000376	0.00182	CcSEcCtD
Rivaroxaban—Dizziness—Etoposide—germ cell cancer	0.000376	0.00182	CcSEcCtD
Rivaroxaban—ABCB1—adrenal gland—germ cell cancer	0.000376	0.00602	CbGeAlD
Rivaroxaban—ABCB1—midbrain—germ cell cancer	0.000371	0.00594	CbGeAlD
Rivaroxaban—Nausea—Cisplatin—germ cell cancer	0.000369	0.00179	CcSEcCtD
Rivaroxaban—ABCB1—bone marrow—germ cell cancer	0.000364	0.00582	CbGeAlD
Rivaroxaban—ABCB1—spinal cord—germ cell cancer	0.000362	0.0058	CbGeAlD
Rivaroxaban—Vomiting—Etoposide—germ cell cancer	0.000362	0.00175	CcSEcCtD
Rivaroxaban—Rash—Etoposide—germ cell cancer	0.000359	0.00174	CcSEcCtD
Rivaroxaban—Dermatitis—Etoposide—germ cell cancer	0.000358	0.00174	CcSEcCtD
Rivaroxaban—Headache—Etoposide—germ cell cancer	0.000356	0.00173	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—germ cell cancer	0.000355	0.00172	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000353	0.00171	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—germ cell cancer	0.000351	0.0017	CcSEcCtD
Rivaroxaban—ABCB1—female gonad—germ cell cancer	0.000351	0.00561	CbGeAlD
Rivaroxaban—Anaphylactic shock—Methotrexate—germ cell cancer	0.000341	0.00165	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—germ cell cancer	0.000338	0.00164	CcSEcCtD
Rivaroxaban—Nausea—Etoposide—germ cell cancer	0.000338	0.00164	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methotrexate—germ cell cancer	0.000334	0.00162	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—germ cell cancer	0.000331	0.0016	CcSEcCtD
Rivaroxaban—ABCB1—endocrine gland—germ cell cancer	0.000326	0.00522	CbGeAlD
Rivaroxaban—ABCB1—head—germ cell cancer	0.000322	0.00515	CbGeAlD
Rivaroxaban—Hypotension—Methotrexate—germ cell cancer	0.000318	0.00154	CcSEcCtD
Rivaroxaban—ABCB1—testis—germ cell cancer	0.000311	0.00498	CbGeAlD
Rivaroxaban—Dyspnoea—Methotrexate—germ cell cancer	0.000304	0.00147	CcSEcCtD
Rivaroxaban—Dyspepsia—Methotrexate—germ cell cancer	0.0003	0.00145	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000294	0.00142	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—germ cell cancer	0.000294	0.00142	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—germ cell cancer	0.000291	0.00141	CcSEcCtD
Rivaroxaban—ABCB1—cerebellum—germ cell cancer	0.000287	0.0046	CbGeAlD
Rivaroxaban—Feeling abnormal—Methotrexate—germ cell cancer	0.000281	0.00136	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000279	0.00135	CcSEcCtD
Rivaroxaban—Urticaria—Methotrexate—germ cell cancer	0.000271	0.00131	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—germ cell cancer	0.000269	0.0013	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—germ cell cancer	0.000251	0.00122	CcSEcCtD
Rivaroxaban—Asthenia—Methotrexate—germ cell cancer	0.000244	0.00118	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—germ cell cancer	0.000241	0.00117	CcSEcCtD
Rivaroxaban—ABCB1—brain—germ cell cancer	0.000233	0.00373	CbGeAlD
Rivaroxaban—Diarrhoea—Methotrexate—germ cell cancer	0.000233	0.00113	CcSEcCtD
Rivaroxaban—ABCB1—lymph node—germ cell cancer	0.000225	0.00361	CbGeAlD
Rivaroxaban—Dizziness—Methotrexate—germ cell cancer	0.000225	0.00109	CcSEcCtD
Rivaroxaban—Vomiting—Methotrexate—germ cell cancer	0.000217	0.00105	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—germ cell cancer	0.000215	0.00104	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—germ cell cancer	0.000215	0.00104	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—germ cell cancer	0.000213	0.00103	CcSEcCtD
Rivaroxaban—Nausea—Methotrexate—germ cell cancer	0.000202	0.00098	CcSEcCtD
